Thematics Asset Management Has $16.14 Million Position in Axon Enterprise, Inc $AXON

Key Points

• Thematics Asset Management increased its stake in Axon Enterprise, Inc by 89.1% in the first quarter, owning 30,691 shares worth approximately $16.14 million.
• Axon Enterprise reported $2.12 earnings per share for the quarter, surpassing analyst expectations of $1.54, with revenues growing by 32.6% year-over-year to $668.54 million.
• Analyst ratings on Axon include Thirteen "Buy" ratings and two "Hold" ratings, with an average target price of $837.69.

Thematics Asset Management increased its position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 89.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 30,691 shares of the biotechnology company's stock after acquiring an additional 14,457 shares during the quarter. Thematics Asset Management's holdings in Axon Enterprise were worth $16,142,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the company. TCTC Holdings LLC lifted its holdings in shares of Axon Enterprise by 75.0% in the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock valued at $29,000 after purchasing an additional 24 shares in the last quarter. Fourth Dimension Wealth LLC purchased a new position in shares of Axon Enterprise during the fourth quarter valued at $30,000. Bartlett & CO. Wealth Management LLC raised its position in Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after buying an additional 33 shares during the period. Catalyst Capital Advisors LLC purchased a new stake in Axon Enterprise in the 1st quarter worth about $32,000. Finally, Alpine Bank Wealth Management acquired a new stake in Axon Enterprise during the 1st quarter worth about $40,000. Hedge funds and other institutional investors own 79.08% of the company's stock.

Axon Enterprise Price Performance

NASDAQ AXON traded up $12.22 on Thursday, reaching $781.90. The company's stock had a trading volume of 550,253 shares, compared to its average volume of 698,679. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The firm has a market cap of $61.38 billion, a PE ratio of 193.06, a price-to-earnings-growth ratio of 28.22 and a beta of 1.36. Axon Enterprise, Inc has a 52 week low of $346.71 and a 52 week high of $885.91. The business has a 50-day moving average price of $772.52 and a 200 day moving average price of $675.87.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating analysts' consensus estimates of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm had revenue of $668.54 million for the quarter, compared to analysts' expectations of $641.77 million. During the same period in the prior year, the business posted $1.20 earnings per share. The business's revenue was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. Sell-side analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on AXON shares. JPMorgan Chase & Co. upped their target price on Axon Enterprise from $730.00 to $850.00 and gave the company an "overweight" rating in a report on Thursday, July 17th. Bank of America boosted their price objective on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. The Goldman Sachs Group increased their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. UBS Group reissued a "neutral" rating and issued a $840.00 price target (up previously from $820.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Finally, Wolfe Research initiated coverage on Axon Enterprise in a research note on Monday, July 7th. They set an "outperform" rating for the company. Thirteen research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $837.69.

Insider Activity

In other Axon Enterprise news, President Joshua Isner sold 15,919 shares of the business's stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $746.26, for a total value of $11,879,712.94. Following the transaction, the president directly owned 238,379 shares in the company, valued at $177,892,712.54. The trade was a 6.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jeffrey C. Kunins sold 7,891 shares of the business's stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $750.10, for a total value of $5,919,039.10. Following the completion of the transaction, the insider directly owned 144,538 shares in the company, valued at $108,417,953.80. The trade was a 5.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 43,790 shares of company stock worth $33,654,451 over the last ninety days. Corporate insiders own 4.40% of the company's stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.